CXCL8 and non-small cell lung carcinoma: To elucidate the underlying mechanism behind the IL‐8‐triggered chemoresistance, we examined IL‐8‐ or IL‐8 blockade antibody‐treated NSCLC cell lines, which were subsequently treated with CM from CAFs‐sh‐CD248 or control CAFs.